Discussion of off-target and tentative genomic findings may sometimes be necessary to allow evaluation of their clinical significance

Abstract

We discuss a case where clinical genomic investigation of muscle weakness unexpectedly found a genetic variant that might (or might not) predispose to kidney cancer. We argue that despite its...